Clinical Trial Update: De-Escalation Therapy for Human Papillomavirus Negative Disease [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for de-escalation therapy in HPV-negative head and neck squamous cell carcinoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: University of Chicago | Conditions: Human Papilloma Virus, Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-05-11